1. Home
  2. PLTK vs STOK Comparison

PLTK vs STOK Comparison

Compare PLTK & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Playtika Holding Corp.

PLTK

Playtika Holding Corp.

HOLD

Current Price

$3.61

Market Cap

1.6B

Sector

Technology

ML Signal

HOLD

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$32.44

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLTK
STOK
Founded
2010
2014
Country
Israel
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.9B
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
PLTK
STOK
Price
$3.61
$32.44
Analyst Decision
Buy
Strong Buy
Analyst Count
9
10
Target Price
$6.61
$34.50
AVG Volume (30 Days)
1.4M
682.6K
Earning Date
02-26-2026
03-17-2026
Dividend Yield
10.70%
N/A
EPS Growth
N/A
N/A
EPS
0.23
0.68
Revenue
$2,726,900,000.00
$205,632,000.00
Revenue This Year
$9.52
$428.87
Revenue Next Year
$2.58
N/A
P/E Ratio
$16.18
$46.68
Revenue Growth
7.49
1128.17
52 Week Low
$3.31
$5.35
52 Week High
$7.55
$38.69

Technical Indicators

Market Signals
Indicator
PLTK
STOK
Relative Strength Index (RSI) 46.23 55.24
Support Level $3.35 $30.75
Resistance Level $3.76 $34.47
Average True Range (ATR) 0.16 2.01
MACD 0.02 0.28
Stochastic Oscillator 57.83 67.31

Price Performance

Historical Comparison
PLTK
STOK

About PLTK Playtika Holding Corp.

Playtika Holding Corp is engaged in developing mobile games. Some of its games include Board Kings, House of Fun, Poker Heat, Slotomania, and Bingo Blitz. The company has built live game operations services and a proprietary technology platform to support its portfolio of games. It derives revenue from the sale of virtual items associated with online games. Geographically, the group has a business presence in the USA, EMEA, APAC, and Other regions of which key revenue is derived from the USA. It offers both Mobile and Web-based platforms.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: